Drugs / bOPV
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT03822754 Background | Jun → Sep 2018 | poliomyelitis | Sinovac Biotech Co., Ltd | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | bOPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03822754 ↗ |
| Modality | Vaccine | “Bivalent Oral Poliovirus Vaccine” NCT03822754 ↗ |
| Route | Oral | “Bivalent Oral Poliovirus Vaccine” NCT03822754 ↗ |